Company / Revenue
Enveric Biosciences, Inc. Revenue History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$43.0M
FY2019
5-year range
$36.1M / $48.6M
FY2017-FY2019
Trend
-11.5%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $36M to $43M over the past 2 years.
Based on SEC 10-K filings.
$43M in FY2019.
Improved from $36M to $43M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, revenue decreased 11.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $43.0M | -11.5% |
| FY2018 | $48.6M | +34.4% |
| FY2017 | $36.1M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026